The combination of GLP-1 and GIP activation explains why dual agonists like Tirzepatide outperform single GLP-1 agonists for both weight and glucose outcomes
98% is considered research-grade, but 99% purity is strongly preferred for tri-receptor binding assays, metabolic studies, and energy expenditure research where compound purity directly affects pharmacological accuracy across all three receptor targets
How Does Lemme Compare to Other Clinics
Weight Management: Many women with PCOS struggle with weight gain and obesity, which can further exacerbate their condition
Noen beskrivelser legger ogs inn tilleggsord for tydeliggjre at tilbudet er del av en velkomstkampanje
*Based on manufacturer trials studying the highest doses of oral Wegovy in non-diabetics with obesity, or with overweight plus a weight-related medical condition, when paired with diet and exercise changes (vs ~2% with diet and exercise alone)